GHK-Cu Peptides

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide bound to a copper ion, first isolated from human blood plasma in 1973 by Dr. Loren Pickart. It is one of the body's primary regenerative signals — regulating over 4,000 genes involved in collagen production, wound healing, hair growth, antioxidant defense, and tissue repair. GHK-Cu levels decline over 50% between ages 20 and 60.

GHK-Cu delivers copper to cells and activates gene expression pathways that promote regeneration. It signals fibroblasts to produce collagen and elastin, stimulates angiogenesis (new blood vessel formation), activates 47 DNA repair genes, and modulates inflammatory responses. It simultaneously stimulates 59% and suppresses 41% of the genes it affects — restoring a more youthful pattern of gene expression.

In a 1-month clinical study, 70% of subjects using GHK-Cu showed increased collagen production, compared to 50% for vitamin C and only 40% for retinoic acid (retinol). Unlike retinol, GHK-Cu does not cause dryness, peeling, irritation, or photosensitivity. It works through gene-level signaling rather than cell turnover, and can be used any time of day without sun sensitivity concerns.

Yes. Research shows GHK-Cu supports hair follicle health through copper-dependent enzymes that enhance scalp blood flow and promote follicle growth. Published studies demonstrate dose-dependent increases in hair count in pattern hair loss cases. Most patients begin noticing reduced shedding within 2-3 months and visible density improvements between 3-6 months. GHK-Cu works through a different mechanism than minoxidil or finasteride.

GHK-Cu has extensive wound healing data. In ischemic wound studies, GHK-Cu treatment achieved 64.5% wound size reduction compared to 45.6% for vehicle-treated and 28.2% for untreated controls. It accelerates healing by stimulating angiogenesis, collagen synthesis, and tissue remodeling. Many patients use it to speed recovery after surgery or to improve scar appearance.

GHK-Cu completely blocks copper-dependent LDL oxidation (vs. only 20% for superoxide dismutase), reduces iron release from ferritin by 87%, and suppresses fibrinogen production by downregulating its gene expression. It calms chronic inflammation without suppressing immune function, making it a powerful systemic antioxidant and anti-inflammatory agent.

Results build progressively. Weeks 1-2: improved skin hydration, reduced redness, and inflammatory modulation. Weeks 4-8: visible reduction in fine lines and wrinkles, improved skin texture and firmness. Months 3-6: significant skin density improvements, scar and hyperpigmentation fading, and initial hair thickness changes. Months 6+: sustained collagen production and continued hair density improvement.

GHK-Cu has an exceptional safety profile with a 300x margin between effective dose (~1 mg/kg) and estimated lethal dose (~330 mg/kg). Common side effects are mild: injection site redness, slight stinging, or temporary swelling. No issues have been reported during its use in skin cosmetics or human wound healing studies. Excessive use may theoretically elevate metalloproteinases — follow your prescribed dosing protocol.

GHK-Cu is administered as a subcutaneous injection, typically 0.5-2.0 mg daily or 5 days per week. Standard protocols cycle 1-2 months on, then off, for 3-6 cycles per year. Each shipment includes lyophilized peptide vials, bacteriostatic water for reconstitution, sterile syringes, alcohol swabs, and step-by-step instructions. Your physician will determine the optimal dose and cycle for your goals.

GHK-Cu is not FDA-approved for therapeutic human use. Topical products containing copper tripeptide-1 are available over-the-counter as cosmetics. Injectable GHK-Cu is prescribed off-label by licensed physicians through compounding pharmacies. It has a strong safety record across decades of use in wound healing and cosmetic applications, with no serious adverse events reported.

GHK-Cu is not appropriate for individuals with Wilson's disease (a copper accumulation disorder), copper allergy, active or suspected cancer (due to angiogenic properties), or those who are pregnant or breastfeeding. It is not recommended for individuals under 18. Patients with a history of anxiety or mood disorders should discuss with their physician, as research in this area is limited.

Injectable GHK-Cu works systemically and does not interact with topical skincare. If you also use topical copper peptide products, avoid combining them in the same routine with retinoids, AHAs, salicylic acid, or vitamin C, as these can destabilize the copper complex. GHK-Cu injections pair well with PRP treatments, radiofrequency tightening, and IV nutrient therapy.

Lyophilized (unreconstituted) GHK-Cu vials should be stored at room temperature, protected from light and moisture. Once reconstituted with bacteriostatic water, vials must be refrigerated at 36-46°F (2-8°C) and used within 30 days. Do not freeze reconstituted vials. Always check the expiration date before use.

GHK-Cu levels will gradually return to your natural baseline after discontinuation. There is no withdrawal or rebound effect. Benefits to skin and hair are cumulative — collagen and elastin produced during treatment remain, but further production slows without continued signaling. Many patients maintain results with periodic maintenance cycles (e.g., 1-2 months on, 1 month off) under physician guidance.